CLIAwaived Drug Testing Products

CLIAwaived products are diagnostic tests that have been granted waived status under the Clinical Laboratory Improvement Amendments (CLIA), meaning they're simple enough to be performed accurately outside a traditional lab setting. For clinics, employers, treatment centers, and workplace testing programs, that distinction matters: waived tests can be run on-site by trained staff without the regulatory burden of moderate- or high-complexity testing, delivering fast, actionable results where they're needed most.

Our current selection centers on urine-based drugs of abuse screening. The Acon Laboratories CLIAwaived 14-Drug Panel with Adulterants ships as 25 individually sealed test cups and covers a broad range of commonly abused substances in a single visual-read format. Because it's an all-in-one cup, the urine sample is collected and screened in the same device?no pouring, pipetting, or separate reagents?with results readable in minutes. The built-in adulterant checks flag attempts to dilute, substitute, or tamper with a specimen, an important safeguard for programs where sample integrity is often challenged.

Buyers evaluating on-site drug screening typically weigh three things: how many drug classes a panel detects, whether it includes adulterant validation, and how straightforward the read is for non-laboratorians. A 14-panel with integrated adulterant strips answers all three, making it well suited to pre-employment screening, probation and compliance monitoring, and substance-use treatment settings where staff need reliable results without shipping specimens off-site. The individually sealed cups also support inventory control and per-test documentation.

Keep in mind that CLIA-waived status still requires operators to obtain a Certificate of Waiver and follow the manufacturer's instructions to maintain accurate, defensible results. Preliminary positive screens should be confirmed by an appropriate laboratory method before any final determination is made.